Effects of imatinib mesylate on cutaneous neurofibromas associated with neurofibromatosis type 1

Imatinib mesylate seemed to inhibit development of cutaneous neurofibromas (c‐NFs) and promote growth of pre‐existing c‐NFs in our neurofibromatosis type 1 case. This report potentially provides new findings in the effects of imatinib mesylate.

Detalles Bibliográficos
Autores principales: Yasuda, Ken‐ichi, Nobeyama, Yoshimasa, Ishiji, Takaoki, Ota, Arihito, Asahina, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669387/
https://www.ncbi.nlm.nih.gov/pubmed/33235741
http://dx.doi.org/10.1002/ccr3.3071
Descripción
Sumario:Imatinib mesylate seemed to inhibit development of cutaneous neurofibromas (c‐NFs) and promote growth of pre‐existing c‐NFs in our neurofibromatosis type 1 case. This report potentially provides new findings in the effects of imatinib mesylate.

Ejemplares similares